Similar articles

• Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.

  Adekola TA. Adekola TA. Public Health. 2019 Aug;173:1-4. doi: 10.1016/j.puhe.2019.04.019. Epub 2019 Jun 13. Public Health. 2019. PMID: 31203136
• TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

  't Hoen E. 't Hoen E. Chic J Int Law. 2002 Spring;3(1):27-46. Chic J Int Law. 2002. PMID: 15709298 No abstract available.
• Should access to medicines and TRIPS flexibilities be limited to specific diseases?

  Outterson K. Outterson K. Am J Law Med. 2008;34(2-3):279-301. doi: 10.1177/009885880803400208. Am J Law Med. 2008. PMID: 18697695 No abstract available.
• [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].

  Chaves GC, Oliveira MA, Hasenclever L, de Melo LM. Chaves GC, et al. Cad Saude Publica. 2007 Feb;23(2):257-67. doi: 10.1590/s0102-311x2007000200002. Cad Saude Publica. 2007. PMID: 17221075 Review. Portuguese.
• Intellectual property protection for plant-related inventions in Europe.

  Fleck B, Baldock C. Fleck B, et al. Nat Rev Genet. 2003 Oct;4(10):834-8. doi: 10.1038/nrg1184. Nat Rev Genet. 2003. PMID: 14526379 Review.